Meeting
2023 ASCO Annual Meeting
Germline variants in non-BRCA1/2 homologous recombination-related genes and ovarian cancer: Analysis of tumor phenotype and survival.
Authors
Ryan M. Kahn
Memorial Sloan Kettering Cancer Center, New York, NY
Ryan M. Kahn , Pier Selenica , Thomas Boerner , Yonghong Xiao , Tiffany Sia , Margaret Sheehan , Qin Zhou , Alexia Iasonos , Rachel N. Grisham , Roisin Eilish O'Cearbhaill , Kara Long , Dennis S Chi , Zsofia Kinga Stadler , Kenneth Offit , Carol Aghajanian , Paul Sabbatini , Diana Mandelker , Dmitriy Zamarin , Britta Weigelt , Ying L Liu
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Gynecologic Cancer
Track
Gynecologic Cancer
Sub Track
Ovarian Cancer
Citation
J Clin Oncol 41, 2023 (suppl 16; abstr 5565)
DOI
10.1200/JCO.2023.41.16_suppl.5565
Abstract #
5565
Poster Bd #
260
Abstract Disclosures
Similar Posters
Poster
2023 ASCO Annual Meeting
The spectrum of homologous recombination deficiency in cervical cancer: Is it also a cervical issue?
First Author: Muhammad Danyal Ahsan
Poster
2022 ASCO Annual Meeting
Detection of homologous recombination deficiency (HRD) in cell-free DNA (cfDNA) using an amplicon-based next-generation sequencing (NGS) assay.
First Author: Jonathan Poh
Poster
2021 ASCO Annual Meeting
Pan-cancer evaluation of homologous repair deficiency somatic mutations and response to first-line anti-neoplastic therapy.
First Author: Jessica A Lavery
Poster
2023 ASCO Annual Meeting
A four-tier classification system for studying homologous recombination repair gene reversion mutations as a mechanism of resistance to PARP inhibitors and platinum chemotherapy.
First Author: Qiuxiang Ou